Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Elypta
Elypta is a Swedish company pioneering a metabolism-based liquid biopsy for early cancer detection. They measure the GAGome, which are system biomarkers of tumor metabolism, and use machine learning…
Elypta
Elypta is a Swedish company pioneering a metabolism-based liquid biopsy for early cancer detection. They measure the GAGome, which are system biomarkers of tumor metabolism, and use machine learning…
TL;DR
Founded: 2017 (Solna, Sweden)
Product: Metabolism‑based liquid biopsy profiling the GAGome for multi-cancer detection and monitoring
Lead programs: Renal cell carcinoma surveillance (AURORAX) and MCED studies (LEVANTIS-series)
Notable funding: $21M Series A (Jun 2022) plus earlier seed/grants
Company Overview
Problem Domain
Early cancer detection and disease monitoring via molecular diagnostics
Founded
2017
Industry
Biotechnology
Funding Track Record
21000000
Raised to develop blood and urine tests for multi‑cancer early detection and kidney cancer recurrence monitoring.
6100000
Late‑seed round (reported as €6.1M) with participation from Sciety, Norrsken Foundation impact fund, Nina Capital and Chalmers Ventures.
Investor Signal
“Bonnier Ventures led Series A; participation from multiple VCs and foundations including Industrifonden, Sciety, Nina Capital, Chalmers Ventures, Norrsken and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week